154 related articles for article (PubMed ID: 34860)
1. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
Bornemisza P; Csögör I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
[No Abstract] [Full Text] [Related]
2. [Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
Bruns W; Rjasanowski I; Wulfert P; Michael R; Knospe S; Hildmann W
Endokrinologie; 1974 Nov; 64(1):2-12. PubMed ID: 4466653
[No Abstract] [Full Text] [Related]
3. Does hypolipidemic therapy prevent coronary heart disease?
Rifkind BM; Levy RI
Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
[No Abstract] [Full Text] [Related]
4. Long-term treatment of hyperlipidemic patients with clofibrate.
Berkowitz D
JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
[No Abstract] [Full Text] [Related]
5. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
6. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
7. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
Krivoruchenko IV; Nikul'cheva NG
Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
[TBL] [Abstract][Full Text] [Related]
8. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
Schwandt P; Weisweiler P; Neureuther G; Wilkening J
MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
[TBL] [Abstract][Full Text] [Related]
9. A study on carbohydrate and lipid metabolism in cases of hyperlipidemia and coronary heart disease. I. Glucose tolerance test and lipid tolerance test.
Chin Med J (Engl); 1978 Nov; 4(6):465-71. PubMed ID: 104838
[No Abstract] [Full Text] [Related]
10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
[No Abstract] [Full Text] [Related]
11. [Hyperlipiemia and its therapy by clofibrate].
Nakano M; Nakamura Y
Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
[No Abstract] [Full Text] [Related]
12. Cholesterol metabolism in patients with coronary heart disease.
Miettinen TA
Ann Clin Res; 1971 Dec; 3(6):313-22. PubMed ID: 5156891
[No Abstract] [Full Text] [Related]
13. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
15. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Hanefeld M; Schulze J; Fritz T; Kemmer C
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
[No Abstract] [Full Text] [Related]
16. Hypolipaemic drugs and coronary heart disease.
Howard AN
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
[No Abstract] [Full Text] [Related]
17. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
[No Abstract] [Full Text] [Related]
18. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
19. [Long-term management of various hyperlipidemias using clofibrate].
Studlar M; Pichler O; Kindler K
Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
[No Abstract] [Full Text] [Related]
20. The influence of clofibrate on glucose tolerance in patients with coronary heart disease.
Ruzyllo E; Szostak WB; Cybulska B
Pol Arch Med Wewn; 1972 Feb; 49(2):121-3. PubMed ID: 4670209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
